Gluskin Sheff + Associates Inc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

GS 17.86 -0.15 (-0.83%)
price chart
Gluskin Sheff + Associates Inc upgraded
Gluskin Sheff + Associates Inc. was upgraded by Scotiabank analyst Phil Hardie as the stock appears oversold relative to its fundamentals.
Gluskin Sheff + Associates Inc (GS) Stock Rating Upgraded by Scotiabank  The Vista Voice
Gluskin Sheff in legal feud with retired co-founders
An arbitrator's decision has opened the door for the two retired co-founders of Gluskin Sheff + Associates Inc. to collect as much as $185-million in payments from their old Bay Street firm.
Gluskin Sheff + Associates Inc. Announces Fourth Quarter and Fiscal 2015 Results
Gluskin Sheff + Associates Inc. is one of Canada's pre-eminent wealth management firms, managing over $8.5 billion on behalf of high net worth private clients, estates, trusts and institutional investors.
Gluskin Sheff + Associates Inc (GS) Price Target Lowered to C$20.00 at Desjardins
Gluskin Sheff + Associates Inc logo Gluskin Sheff + Associates Inc (TSE:GS) had its target price trimmed by Desjardins from C$21.00 to C$20.00 in a report published on Friday morning, AnalystRatings.
Gluskin Sheff + Associates Inc. announces the retirement of Jeremy Freedman ...
TORONTO, April 7, 2016 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") announced today that Jeremy Freedman has indicated his intention to retire as President & Chief Executive Officer and a director of the Company effective June 30, 2016, the ...
RBC Capital Trims Gluskin Sheff + Associates Inc (GS) Target Price to C$21.00  Web Breaking News
Gluskin Sheff CEO to retire  The Globe and Mail (subscription)
RBC Capital Lowers Gluskin Sheff + Associates Inc (GS) Price Target to C$20.00
Gluskin Sheff + Associates logo Gluskin Sheff + Associates Inc (TSE:GS) had its price target dropped by research analysts at RBC Capital from C$21.00 to C$20.00 in a research report issued on Wednesday, Marketbeat reports.
Desjardins Lowers Gluskin Sheff + Associates Inc (GS) Price Target to C$20.00  Web Breaking News
Could Gluskin Sheff + Associates Inc Change Direction After Today's Huge ...  CCH Daily News
Gluskin Sheff + Associates Inc. Third Quarter Fiscal 2016 Results and ...
TORONTO, April 13, 2016 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") will issue its financial results for the three months ended March 31, 2016 in the afternoon of Thursday, May 12, 2016.
Brokerages Set Gluskin Sheff + Associates Inc (TSE:GS) Target Price at $22.81
Gluskin Sheff + Associates logo Gluskin Sheff + Associates Inc (TSE:GS) has been given a consensus recommendation of “Buy” by the eight ratings firms that are currently covering the company, MarketBeat reports.
Gluskin Sheff + Associates Inc (GS) Price Target Lowered to C$20.00 at RBC ...  Mas Market News
Gluskin Sheff & Assoc Inc. Has $34866000 Stake in Allergan, Inc. (AGN)
Allergan logo Gluskin Sheff & Assoc Inc. cut its stake in Allergan, Inc. (NYSE:AGN) by 50.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Gluskin Sheff + Associates Inc. Announces March 31, 2016 Assets Under Management
TORONTO, April 15, 2016 /CNW/ - Gluskin Sheff + Associates Inc. (the "Company") announced today its estimated Assets Under Management ("AUM") as at March 31, 2016, and the components of the change in AUM.